Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Randomised Phase 2 Trial of Docetaxel With or Without AZD6244 in wt BRAF Advanced Melanoma

NCT01256359 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT01256359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01256359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Randomised Phase 2 Trial of Docetaxel With or Without AZD6244 in wt BRAF Advanced Melanoma
Lead sponsor
University of Oxford
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2010
Completion date
February 29, 2020
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma